Dimension Therapeutics, Inc. General and Administrative Expense
Dimension Therapeutics, Inc. reported General and Administrative Expense of $5.32 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2017-11-06
- Dimension Therapeutics, Inc. general and administrative expense for the quarter ending 2017-09-30 was $5.32M, a 60.97% increase year-over-year.
- Dimension Therapeutics, Inc. general and administrative expense for the quarter ending 2017-06-30 was $2.61M, a 19.34% decline year-over-year.
- Dimension Therapeutics, Inc. general and administrative expense for the quarter ending 2017-03-31 was $3.43M, a 16.70% increase year-over-year.
- Dimension Therapeutics, Inc. general and administrative expense for the quarter ending 2016-12-31 was $3.30M, a 26.46% increase year-over-year.
- Dimension Therapeutics, Inc. general and administrative expense for fiscal 2016 was $12.78M, a 46.51% increase from fiscal 2015.
- Dimension Therapeutics, Inc. general and administrative expense for fiscal 2015 was $8.72M, a 219.88% increase from fiscal 2014.
- Dimension Therapeutics, Inc. general and administrative expense for fiscal 2014 was $2.73M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $5.32M 10-Q · filed 2017-11-06 | $7.93M derived: sum of 2 quarters · filed 2017-11-06 | $11.36M 10-Q · filed 2017-11-06 | $14.66M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | $2.61M 10-Q · filed 2017-08-08 | $6.04M 10-Q · filed 2017-08-08 | $9.34M derived: sum of 3 quarters · filed 2017-08-08 | $12.64M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | $3.43M 10-Q · filed 2017-05-10 | $6.73M derived: sum of 2 quarters · filed 2017-05-10 | $10.04M derived: sum of 3 quarters · filed 2017-11-06 | $13.27M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $6.60M derived: sum of 2 quarters · filed 2017-11-06 | $9.84M derived: sum of 3 quarters · filed 2017-11-06 | $12.78M 10-K · filed 2017-03-09 |
| 2016-09-30 | $3.31M 10-Q · filed 2017-11-06 | $6.54M derived: sum of 2 quarters · filed 2017-11-06 | $9.48M 10-Q · filed 2017-11-06 | $12.09M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $3.24M 10-Q · filed 2017-08-08 | $6.18M 10-Q · filed 2017-08-08 | $8.79M derived: sum of 3 quarters · filed 2017-08-08 | $11.12M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $2.94M 10-Q · filed 2017-05-10 | $5.55M derived: sum of 2 quarters · filed 2017-05-10 | $7.88M derived: sum of 3 quarters · filed 2017-05-10 | $10.21M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $4.94M derived: sum of 2 quarters · filed 2017-03-09 | $7.27M derived: sum of 3 quarters · filed 2017-03-09 | $8.72M 10-K · filed 2017-03-09 |
| 2015-09-30 | $2.33M 10-Q · filed 2016-11-10 | $4.66M derived: sum of 2 quarters · filed 2016-11-10 | $6.12M 10-Q · filed 2016-11-10 | $7.31M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $2.33M 10-Q · filed 2016-08-11 | $3.78M 10-Q · filed 2016-08-11 | $4.97M derived: sum of 3 quarters · filed 2017-03-09 | $5.42M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $1.45M 10-Q · filed 2016-05-12 | $2.64M derived: sum of 2 quarters · filed 2017-03-09 | $3.10M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2014-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.64M derived: sum of 2 quarters · filed 2017-03-09 | $2.73M 10-K · filed 2017-03-09 | |
| 2014-09-30 | $451.00K 10-Q · filed 2015-12-04 | $1.54M 10-Q · filed 2015-12-04 | ||
| 2013-12-31 | $364.00K 10-K · filed 2016-03-24 |